JAMIE LOBELL: Open Payments
NPI 1164961751 · PRAIRIEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 37 payments from 14 companies in 2025. Trend: 2023 $724 · 2024 $587 · 2025 $677
Food & beverage: $677
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $94 |
| GlaxoSmithKline, LLC. | 5 | $90 |
| Lilly USA, LLC | 5 | $87 |
| ABBVIE INC. | 4 | $83 |
| PFIZER INC. | 4 | $79 |
| Corium, LLC | 4 | $67 |
| SANOFI-AVENTIS U.S. LLC | 2 | $36 |
| Abbott Laboratories | 1 | $31 |
| SANOFI PASTEUR INC. | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
Products named: MOUNJARO, Azstarys, PREVNAR 20, AREXVY, QULIPTA, TZIELD, SHINGRIX, FREESTYLE LIBRE 3.
Industry payments across LA — which companies pay providers there.
